These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33159999)

  • 1. Burden of influenza B virus infection and considerations for clinical management.
    Zaraket H; Hurt AC; Clinch B; Barr I; Lee N
    Antiviral Res; 2021 Jan; 185():104970. PubMed ID: 33159999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.
    Takashita E; Daniels RS; Fujisaki S; Gregory V; Gubareva LV; Huang W; Hurt AC; Lackenby A; Nguyen HT; Pereyaslov D; Roe M; Samaan M; Subbarao K; Tse H; Wang D; Yen HL; Zhang W; Meijer A
    Antiviral Res; 2020 Mar; 175():104718. PubMed ID: 32004620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of the Frequency of Prescription and Pharmacy Revisits between Baloxavir Marboxil and Neuraminidase Inhibitors in Influenza-Infected Pediatric Patients during the 2019-2020 Influenza Season.
    Norikoshi Y; Ikeda T; Sasahara K; Hamada M; Torigoe E; Nagae M; Tashiro T; Horio F; Saruwatari J; Uchida Y; Anraku M
    Biol Pharm Bull; 2020; 43(12):1960-1965. PubMed ID: 33268716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitness of influenza A and B viruses with reduced susceptibility to baloxavir: A mini-review.
    Abed Y; Saim-Mamoun A; Boivin G
    Rev Med Virol; 2021 May; 31(3):e2175. PubMed ID: 32975358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xofluza Now Indicated to Prevent Influenza.
    Aschenbrenner DS
    Am J Nurs; 2021 Feb; 121(2):26-27. PubMed ID: 33497124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir.
    Salvatore M; Laplante JM; Soave R; Orfali N; Plate M; van Besien K; St George K
    Transpl Infect Dis; 2020 Aug; 22(4):e13336. PubMed ID: 32449254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza.
    Szollosi D; Bill A
    Curr Drug Targets; 2020; 21(2):202-211. PubMed ID: 31368872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase inhibitors and single dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials.
    Tejada S; Tejo AM; Peña-López Y; Forero CG; Corbella X; Rello J
    Expert Rev Clin Pharmacol; 2021 Jul; 14(7):901-918. PubMed ID: 33861168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baloxavir Marboxil: A Review in Acute Uncomplicated Influenza.
    Shirley M
    Drugs; 2020 Jul; 80(11):1109-1118. PubMed ID: 32601915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children: A Systematic Review and Network Meta-analysis.
    Liu JW; Lin SH; Wang LC; Chiu HY; Lee JA
    JAMA Netw Open; 2021 Aug; 4(8):e2119151. PubMed ID: 34387680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-Emergent Influenza Virus Polymerase Acidic Substitutions Independent of Those at I38 Associated With Reduced Baloxavir Susceptibility and Virus Rebound in Trials of Baloxavir Marboxil.
    Ince WL; Smith FB; O'Rear JJ; Thomson M
    J Infect Dis; 2020 Aug; 222(6):957-961. PubMed ID: 32253432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early combination treatment with baloxavir and peramivir for hospitalized adults with influenza A in Yokohama, Japan.
    Yoshimura Y; Sasaki H; Horiuchi H; Miyata N; Kawakami C; Usuku S; Tachikawa N
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1637-1640. PubMed ID: 32291543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baloxavir treatment of oseltamivir-resistant influenza A/H1pdm09 in two immunocompromised patients.
    Macesic N; Laplante JM; Aaron JG; DiMango EA; Miko BA; Pereira MR; Reshef R; St George K
    Transpl Infect Dis; 2021 Jun; 23(3):e13542. PubMed ID: 33278052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
    Kumar D; Ison MG; Mira JP; Welte T; Hwan Ha J; Hui DS; Zhong N; Saito T; Katugampola L; Collinson N; Williams S; Wildum S; Ackrill A; Clinch B; Lee N
    Lancet Infect Dis; 2022 May; 22(5):718-730. PubMed ID: 35085510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018-2019 season and detection of variant influenza a viruses with polymerase acidic subunit substitutions.
    Saito R; Osada H; Wagatsuma K; Chon I; Sato I; Kawashima T; Saito T; Kodo N; Ono Y; Shimada Y; Phyu W; Shobugawa Y
    Antiviral Res; 2020 Nov; 183():104951. PubMed ID: 32987032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Variants With Reduced Baloxavir Marboxil Susceptibility After Treatment of Children With Influenza A During the 2018-2019 Influenza Season.
    Sato M; Takashita E; Katayose M; Nemoto K; Sakai N; Hashimoto K; Hosoya M
    J Infect Dis; 2020 Jun; 222(1):121-125. PubMed ID: 32034420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials.
    Kuo YC; Lai CC; Wang YH; Chen CH; Wang CY
    J Microbiol Immunol Infect; 2021 Oct; 54(5):865-875. PubMed ID: 34020891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor.
    Todd B; Tchesnokov EP; Götte M
    J Biol Chem; 2021; 296():100486. PubMed ID: 33647314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice.
    Abed Y; Fage C; Checkmahomed L; Venable MC; Boivin G
    Antiviral Res; 2020 Jul; 179():104807. PubMed ID: 32343991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study.
    Yokoyama T; Sakaguchi H; Ishibashi T; Shishido T; Piedra PA; Sato C; Tsuchiya K; Uehara T
    Pediatr Infect Dis J; 2020 Aug; 39(8):706-712. PubMed ID: 32433222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.